SHANGHAI, China, August 24, 2021 /PRNewswire/-- Reistone Biopharma (“Reistone”), a leading biotech focused on development of treatments for immune & inflammation related diseases....
SHANGHAI, Jan. 20, 2021—Reistone Biopharma Co. Ltd. (“Reistone”), a clinical stage biopharmaceutical company focused on developing novel medicines for immuno-inflammatory, diseases with high unmet medical needs, today announced that SHR0302, an investigat
